As CCND1 aberrations are known to contribute to neuroblastoma, this might explain why, as opposed to individuals with MYCNThr58Met, individuals with the MAXArg60Gln variant do not have neuroblastoma, despite the overlapping phenotypes and underlying molecular mechanisms. Here, CCND1 is linked to neuroblastoma.